Phosphorylation of several proteins including Src, ERK1/2, EGFR, Akt, STAT-2 and Chk-2 were significantly reduced in GZ17-treated HNSCC (ED50 dose) (Fig. 3A,B). This evidence concerns the gene MAPK3 and head and neck squamous cell carcinoma.